Catalyst Wire Dossier Catalyst Wire Dossier

Treg gene-modified regulatory T cell therapy

· Sonoma Biotherapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Treg gene-modified regulatory T cell therapy, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

See pricing